Nerve Renew is a dietary supplement designed to address neurological problems and restore healthy nerve function. The formula ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

H.C. Wainwright reiterated its Buy rating on OKYO Pharma Ltd. (NASDAQ: OKYO) with a price target of $7.00, representing significant upside potential from the current trading price of $1.10. According ...

The son of famous Australian surfer Wayne 'Rabbit' Bartholomew AM began suffering intense bouts of pain around his ear and ...

In recent years, the conversation surrounding cannabis and its medicinal properties has gained considerable momentum.

If walking is becoming difficult and physio isn’t working, cutting-edge treatments could be the next step. But which ones are ...

As an orthopedic and sports medicine surgeon and chairman at Inova Sports Medicine, Dr. Robin West is no stranger to sports-related injuries. She understands that developing an effective game plan to ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...

It was a fluke accident that led to a long journey for Harper. One hot summer day in 2024, Harper fell from an above-ground pool with her arms extended out, resulting in extreme, lasting pain. The ...

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.